Congress funds research into a condition hitting Black women hardest
S. 2531 — Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 · Filed by Angela Alsobrooks (D-MD) · 4 cosponsors · Introduced Jul 30, 2025 · Hearing held
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Secretary of Health and Human Services to fund research on early detection of uterine fibroids and to award grants to states for screening programs, patient navigation services, and public awareness campaigns. It also funds research into pain management disparities in fibroid treatment and related intrauterine conditions, with biennial reporting to Congress on findings.
Why we flagged it
The bill is a straightforward public health measure authorizing federal research funding and state grant programs to improve early detection and treatment of uterine fibroids, a common gynecological condition.
What the text implies
- By funding research into pain management disparities, the bill implicitly acknowledges and addresses documented racial disparities in fibroid care and pain treatment, which may drive systemic improvements in how gynecological pain is managed across populations.
- State grant programs may create new infrastructure for advanced gynecological imaging and patient navigation that could benefit broader women's health screening beyond fibroids.
- Biennial reporting requirement creates ongoing congressional oversight and public transparency on research findings, establishing a feedback loop for evidence-based policy updates.
Who it affects
The bill expands access to screening, early detection, and treatment for a condition affecting millions of women, particularly Black women who experience higher rates and severity. It funds public health infrastructure and research into health disparities, with no apparent costs to ordinary citizens.
Who stands to gain
- medical imaging equipment manufacturers
- healthcare systems and hospitals
- research institutions and universities
- patient advocacy organizations
Named in the bill
Secretary of Health and Human Services, Department of Health and Human Services, States (grant recipients), Asherman's Syndrome, intrauterine adhesions
Where it stands
4 cosponsors: 2 Democrats, 2 Republicans.
- Jul 30, 2025 — Introduced · Congress.gov: “Introduced in Senate”
- Jul 30, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”
- Mar 19, 2026 — Hearing held · Congress.gov: “Committee on Health, Education, Labor, and Pensions. Hearings held”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Dec 2025 to Dec 2025. Those filings disclosed $351,373 in lobbying spend. A filing names 11 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 41% of bills with at least one filing.
Angela Alsobrooks, the sponsor, reported $493,679 in PAC receipts in the 2026 cycle.
- American Apparel & Footwear Association — $343,644 on 1 filing
- Travel Goods Association — $7,729 on 1 filing
Lobbying Disclosure Act filings through Jan 16, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 6, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Dec 2025 to Dec 2025. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jan 16, 2026 · page rendered 2026-10-20.
“Congress funds research into a condition hitting Black women hardest” QuorumCivic. https://share.quorumcivic.app/bill/119/s2531 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.